Economic effects of insomnia
- PMID: 7859246
Economic effects of insomnia
Abstract
Insomnia affects up to 40% of the general population yearly and is a significant cause of morbidity and mortality. The direct and indirect costs of insomnia place a tremendous economic burden on society and employers. In addition to the cost of medical treatment and drugs, measurable costs of insomnia include reduced productivity, increased absenteeism, accidents, and hospitalization, as well as medical costs due to increased morbidity and mortality, depression due to insomnia, and increased alcohol consumption. This article reviews the literature on the economic costs and effects associated with insomnia. Based on the data reviewed, a conservative estimate of the total annual cost of insomnia was calculated at $92.5 to $107.5 billion. Early recognition and treatment of insomnia can reduce the costs associated with the condition, as well as possibly prevent other illnesses.
Similar articles
-
Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents.Sleep Med. 2009 Apr;10(4):427-38. doi: 10.1016/j.sleep.2008.04.005. Epub 2008 Aug 26. Sleep Med. 2009. PMID: 18753000
-
Economic costs of diabetes in the U.S. In 2007.Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review.
-
Comorbid insomnia: current directions and future challenges.Am J Manag Care. 2009 Feb;15 Suppl:S6-13. Am J Manag Care. 2009. PMID: 19298104 Review.
-
The direct economic costs of insomnia in the United States for 1995.Sleep. 1999 May 1;22 Suppl 2:S386-93. Sleep. 1999. PMID: 10394612
-
The economic impact of insomnia in managed care: a clearer picture emerges.Am J Manag Care. 2006 May;12(8 Suppl):S246-52. Am J Manag Care. 2006. PMID: 16686594
Cited by
-
Molecular basis of ligand selectivity for melatonin receptors.RSC Adv. 2023 Feb 1;13(7):4422-4430. doi: 10.1039/d2ra06693a. eCollection 2023 Jan 31. RSC Adv. 2023. PMID: 36760312 Free PMC article.
-
A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience.Drug Saf. 1999 Dec;21(6):457-69. doi: 10.2165/00002018-199921060-00003. Drug Saf. 1999. PMID: 10612270 Review.
-
The development of a new corporate specific health risk measurement instrument, and its use in investigating the relationship between health and well-being and employee productivity.Environ Health. 2005 Jan 28;4(1):1. doi: 10.1186/1476-069X-4-1. Environ Health. 2005. PMID: 15679885 Free PMC article.
-
Sleep disturbances are related to decreased transmission of blue light to the retina caused by lens yellowing.Sleep. 2011 Sep 1;34(9):1215-9. doi: 10.5665/SLEEP.1242. Sleep. 2011. PMID: 21886359 Free PMC article.
-
Cognitive behavioural interventions for sleep problems in adults aged 60+.Cochrane Database Syst Rev. 2002;2003(2):CD003161. doi: 10.1002/14651858.CD003161. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2003;(1):CD003161. doi: 10.1002/14651858.CD003161. PMID: 12076472 Free PMC article. Updated.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical